Apyx Medical
APYX· Manufacturing· Fiscal year ends in December
Charles D. Goodwin is the CEO of Apyx Medical and was paid $1.2M in FY2025 (Dec), up 26%.
Executives4
See all- 1Charles D. GoodwinCEO and DirectorFY2025
- 2Mathew HillCFO, Treasurer and SecretaryFY2025
- 3Shawn RomanChief Operating OfficerFY2025
- 4Moshe CitronowiczSenior Vice PresidentFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allApyx Medical paid its 4 named executives $3.2M in total in FY2025 (Dec). CEO Charles D. Goodwin was paid $1.2M of that.
| Name | |||
|---|---|---|---|
| Charles D. GoodwinCEO and Director | |||
| Mathew HillCFO, Treasurer and Secretary | |||
| Shawn RomanChief Operating Officer | Not disclosed | ||
| Moshe CitronowiczSenior Vice President |
of each named executive, from the Summary Compensation Table of each proxy.
Peers11
See allThe FY2025 (Dec) proxy of Apyx Medical names 11 peer companies for pay. Among Apyx Medical and these peers, CEO pay was 2nd highest of 3 and total shareholder return was 2nd highest of 3.
2nd highest of 3in Apyx Medical and its pay peers, FY2025 (Dec) by CEO pay:
2nd highest of 3in Apyx Medical and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board1
See all- Minnie Baylor-HenryDirector · 6 yr on the boardIndependentAudit, Compensation, Governance and Nominating, Regulatory Compliance (Chair)—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Jun 26, 2026 | FY2025 |
| Annual report | 10-K | Mar 10, 2026 | FY2025 |
| Proxy statement | DEF 14A | Jun 25, 2025 | FY2024 |
| Annual report | 10-K | Mar 13, 2025 | FY2024 |
| Proxy statement | DEF 14A | Jun 25, 2024 | FY2023 |
| Annual report | 10-K | Mar 21, 2024 | FY2023 |